SEC Settles Insider Trading Case Against Robert Yedid, Andrew Kaufman, and Mark Jacobs for $595,538
The SEC secured proposed final consent judgments against three defendants in an insider trading scheme that generated more than $500,000 in unlawful profits from pharmaceutical and biotechnology company trades.
